Northwestern | Proteomics, home of the National Resource for Translational and Developmental Proteomics (NRTDP) is developing better antibody-based test for Coronavirus, COVID-19 improved blood testing.

Leveraging state-of-the-art mass spectrometry programs and years of successful experience , Northwestern | Proteomics is prepared to offer Top Down mass spec analysis of SARS-CoV-2 proteins. The depth and accuracy of the data that Northwestern Proteomics can deliver about viral proteins could prove to be an invaluable resource in help identify a vaccine for the Coronavirus.

Researchers, around the world, are expending every effort to identify a potential vaccine for the virus. When they do, Northwestern | Proteomics is ready to analyze that vaccine and offer researchers the most accurate protein profile possible.